CIAM
PDSB icon

Caitong International Asset Management’s PDS Biotechnology PDSB Stock Holding History

Caitong International Asset Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$1 – 2370
2025
Q2 		$1 Hold
1
– – ﹤0.01% 1932
2025
Q1 		$1 Sell
1
-246
-100% -$350 ﹤0.01% 2114
2024
Q4 		$403 Buy
+247
New +$654 ﹤0.01% 1493

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's PDSB Position: Q3 2025 in Review

Caitong International Asset Management sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 1 share — an estimated $1 sold.

Caitong International Asset Management first reported a position in PDSB in Q4 2024 and held it in 3 quarters. The position peaked at $403 in Q4 2024. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Caitong International Asset Management reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 1 PDS Biotechnology share in Q3 2025, an estimated $1.
  • Caitong International Asset Management first reported a position in PDS Biotechnology in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's PDS Biotechnology position peaked at $403 in Q4 2024.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.